Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-392]
 ACTION: Notice of application.
 DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before October 16, 2017. Such persons may also file a written request 
 
 for a hearing on the application on or before October 16, 2017.
 ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.


SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (“Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on July 13, 2017, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665 applied to be registered as an importer of the following basic classes of controlled substances: Controlled substance
Drug code
Schedule3-Fluoro-N-methylcathinone (3-FMC)
1233
ICathinone
1235
IMethcathinone
1237
I4-Fluoro-N-methylcathinone (4-FMC)
1238
IPentedrone (α-methylaminovalerophenone)
1246
IMephedrone (4-Methyl-N-methylcathinone)
1248
I4-Methyl-N-ethylcathinone (4-MEC)
1249
INaphyrone
1258
IN-Ethylamphetamine
1475
IN,N-Dimethylamphetamine
1480
IFenethylline
1503
IMethaqualone
2565
IJWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole)
6250
ISR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole)
7008
I5-Flouro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone
7011
IAB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)
7012
IJWH-019 (1-Hexyl-3-(1-naphthoyl)indole)
7019
IAB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)
7023
ITHJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone
7024
IAB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
7031
IADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide)
7035
IAPINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide
7048
IJWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole)
7081
ISR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole
7104
IJWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole)
7118
IJWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole)
7122
IUR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
7144
IJWH-073 (1-Butyl-3-(1-naphthoyl)indole)
7173
IJWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole)
7200
IAM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole)
7201
IJWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole)
7203
IPB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate)
7222
I5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate)
7225
IAlpha-ethyltryptamine
7249
IIbogaine
7260
ICP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol)
7297
ICP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol)
7298
ILysergic acid diethylamide
7315
I2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7)
7348
IMarihuana
7360
IParahexyl
7374
IMescaline
7381
I2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 )
7385
I3,4,5-Trimethoxyamphetamine
7390
I4-Bromo-2,5-dimethoxyamphetamine
7391
I4-Bromo-2,5-dimethoxyphenethylamine
7392
I4-Methyl-2,5-dimethoxyamphetamine
7395
I2,5-Dimethoxyamphetamine
7396
IJWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole)
7398
I3,4-Methylenedioxyamphetamine
7400
I5-Methoxy-3,4-methylenedioxyamphetamine
7401
IN-Hydroxy-3,4-methylenedioxyamphetamine
7402
I3,4-Methylenedioxy-N-ethylamphetamine
7404
I3,4-Methylenedioxymethamphetamine
7405
I4-Methoxyamphetamine
7411
I( print page 43406)5-Methoxy-N-N-dimethyltryptamine
7431
IAlpha-methyltryptamine
7432
IBufotenine
7433
IDiethyltryptamine
7434
IDimethyltryptamine
7435
IPsilocybin
7437
IPsilocyn
7438
I5-Methoxy-N,N-diisopropyltryptamine
7439
IN-Ethyl-1-phenylcyclohexylamine
7455
I1-(1-Phenylcyclohexyl)pyrrolidine
7458
I1-[1-(2-Thienyl)cyclohexyl]piperidine
7470
IN-Benzylpiperazine
7493
I4-Methyl-alphapyrrolidinopropiophenone (4-MePPP)
7498
I2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)
7508
I2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E )
7509
I2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)
7517
I2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)
7518
I2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)
7519
I2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N)
7521
I2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P)
7524
I2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4 )
7532
IMDPV (3,4-Methylenedioxypyrovalerone)
7535
I2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe)
7536
I2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe)
7537
I2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe)
7538
IMethylone (3,4-Methylenedioxy-N-methylcathinone)
7540
IButylone
7541
IPentylone
7542
Ialpha-pyrrolidinopentiophenone (α-PVP)
7545
Ialpha-pyrrolidinobutiophenone (α-PBP)
7546
IAM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole)
7694
IDesomorphine
9055
IEtorphine (except HCl)
9056
ICodeine methylbromide
9070
IHeroin
9200
IMorphine-N-oxide
9307
INormorphine
9313
IPholcodine
9314
IU-47700 (3,4-dichloro-N-[2-dimethylamino)cyclohexy]-N-methylbenzamide)
9547
IAH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide))
9551
IAcetylmethadol
9601
IAllylprodine
9602
IAlphacetylmethadol except levo-alphacetylmethadol
9603
IAlphameprodine
9604
IAlphamethadol
9605
IBetacetylmethadol
9607
IBetameprodine
9608
IBetamethadol
9609
IBetaprodine
9611
IDextromoramide
9613
IDipipanone
9622
IHydroxypethidine
9627
INoracymethadol
9633
INorlevorphanol
9634
INormethadone
9635
IRacemoramide
9645
ITrimeperidine
9646
I1-Methyl-4-phenyl-4-propionoxypiperidine
9661
ITilidine
9750
IPara-Fluorofentanyl
9812
I3-Methylfentanyl
9813
IAlpha-methylfentanyl
9814
IAcetyl-alpha-methylfentanyl
9815
IBeta-hydroxyfentanyl
9830
IBeta-hydroxy-3-methylfentanyl
9831
IAlpha-methylthiofentanyl
9832
I3-Methylthiofentanyl
9833
IThiofentanyl
9835
IMethamphetamine
1105
IIMethylphenidate
1724
IIAmobarbital
2125
IIPentobarbital
2270
IISecobarbital
2315
IIGlutethimide
2550
II( print page 43407)Nabilone
7379
II1-Phenylcyclohexylamine
7460
IIPhencyclidine
7471
IIPhenylacetone
8501
II1-Piperidinocyclohexanecarbonitrile
8603
IIAlphaprodine
9010
IIDihydrocodeine
9120
IIEcgonine
9180
IIEthylmorphine
9190
IILevomethorphan
9210
IILevorphanol
9220
IIMeperidine
9230
IIDextropropoxyphene, bulk (non-dosage forms)
9273
IILevo-alphacetylmethadol
9648
IINoroxymorphone
9668
IIRacemethorphan
9732
IIAlfentanil
9737
IIRemifentanil
9739
IISufentanil
9740
IICarfentanil
9743
IITapentadol
9780
II
 The company plans to import small quantities of the listed controlled substances for the manufacture of analytical reference standards and distribution to their research and forensic customers. In reference to drug code 7360 the company plans to import a synthetic cannabidiol. No other activity for this drug code is authorized for this registration. Placement of these drug codes onto the company's registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approval or non-approved finished dosage forms for commercial sale. Dated: August 31, 2017. Demetra Ashley, Acting Assistant Administrator.


[FR Doc. 2017-19067 Filed 9-14-17; 8:45 am] BILLING CODE 4410-09-P